![Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities](https://oncodaily.com/pub/uploads/2023/07/Aaron-Goodman-e1723462958200-1280x1261.jpeg)
Photo from Aaron Goodman/X
Aug 12, 2023, 16:19
Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
In a post on Twitter by Aaron Goodman, Hematologist/Bone Marrow Transplanter at UCSD, it says, “diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
Another drug that was FDA approved on single arm data. Looks like it’s toxic. Maybe should come off market.”
For the article click here
Source:Aaron Goodman / Twitter